	US 11,911,428 B2
	Medicinal ambrosia maritima extracts
Sherine Hassan Abbas Helmy, Alexandria (EG); Layla Mohamed Fakhr El-Din El-Sawy, Alexandria (EG); and Mohamed Gomaa Seadawy Khamis, Sinnuris (EG)
Filed by Sherine Hassan Abbas Helmy, Alexandria (EG); Layla Mohamed Fakhr El-Din El-Sawy, Alexandria (EG); and Mohamed Gomaa Seadawy Khamis, Sinnuris (EG)
Filed on May 12, 2021, as Appl. No. 17/317,974.
Prior Publication US 2022/0362321 A1, Nov. 17, 2022
Int. Cl. A61K 36/28 (2006.01); A61K 31/365 (2006.01); A61P 31/14 (2006.01)

CPC A61K 36/28 (2013.01) [A61K 31/365 (2013.01); A61P 31/14 (2018.01); A61K 2236/35 (2013.01); A61K 2236/39 (2013.01)]

10 Claims

1. A method of treating a coronavirus infection, comprising administering an effective amount of a composition comprising a polar organic extract of a whole Ambrosia maritima plant together with a pharmaceutically acceptable carrier to a patient with a coronavirus infection, wherein the coronavirus infection is SARS-CoV-2 infection.